News EU drug regulators concerned about Brexit impact European regulators concerned over impact of EMA move.
News Life Sciences at heart of UK’s new Industrial Strategy No guarantee of funding for new medicines funding - which is being squeezed again
Views & Analysis Never waste a crisis: Can a new life sciences strategy be f... Andrew McConaghie speaks to UK pharma industry leaders about Brexit and what is needed to create a meaningful, long-term life sciences strategy.
News Brexit could disrupt EU drug approvals - EMA chief Moving EMA could slow approval process, warns Guido Rasi
Views & Analysis Minister for Life Sciences and Brexit: UK pharma better get ... Lord Prior, Department of Health minister in charge of relations with pharma and Brexit, discusses exiting the EU, the promised UK Life Sciences strategy and the future of pharma pric
Views & Analysis Getting it right: the UK’s pathway for 2017 The implications for global pharma HQs and what the UK needs to do.
News J&J adds rare disease wAIHA to Imaavy's potential uses Johnson & Johnson's 'Swiss army knife' drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
